3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
2
Stomach Neoplasms
1
Advanced Non-Small Cell Lung Cancer
1
Adenocarcinoma Of Esophagus
1
Interventions
Oxaliplatin
24
Fluorouracil
20
Capecitabine
16
pembrolizumab
15
Nivolumab
15
Leucovorin
13
Trastuzumab
9
fludarabine
8
Paclitaxel
8
Drug Therapy
8
Docetaxel
8
Cyclophosphamide
8
S 1 (combination)
7
trastuzumab deruxtecan
6
Specimen Handling
6
Cisplatin
6
Magnetic Resonance Spectroscopy
5
Bevacizumab
5
zolbetuximab
4
Irinotecan
4
Biopsy
4
zimberelimab
3
sintilimab
3
fludarabine phosphate
3
atezolizumab
3
aldesleukin
3
XELOX
3
Surgical Procedures, Operative
3
Ramucirumab
3
Radiotherapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
quemliclustat
×
90 days
×
Clear all
NCT05329766
2026-06-02
EDGE-Gastric
Arcus Biosciences, Inc.
Phase 2
Active not recruiting
332 enrolled